370 related articles for article (PubMed ID: 28980857)
21. Amelioration of hyperoxaluria-induced kidney dysfunction by chemical chaperone 4-phenylbutyric acid.
Randhawa R; Bhardwaj R; Kaur T
Urolithiasis; 2019 Apr; 47(2):171-179. PubMed ID: 29947992
[TBL] [Abstract][Full Text] [Related]
22. Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis.
Gambaro G; Valente ML; Zanetti E; Della Barbera M; Del Prete D; D'Angelo A; Trevisan A
J Am Soc Nephrol; 2006 Aug; 17(8):2213-9. PubMed ID: 16790510
[TBL] [Abstract][Full Text] [Related]
23. Kidney injury molecule-1 is up-regulated in renal epithelial cells in response to oxalate in vitro and in renal tissues in response to hyperoxaluria in vivo.
Khandrika L; Koul S; Meacham RB; Koul HK
PLoS One; 2012; 7(9):e44174. PubMed ID: 22984472
[TBL] [Abstract][Full Text] [Related]
24. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition.
Verhulst A; Dehmel B; Lindner E; Akerman ME; D'Haese PC
Urolithiasis; 2022 Apr; 50(2):119-130. PubMed ID: 35122487
[TBL] [Abstract][Full Text] [Related]
25. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
Thamilselvan S; Hackett RL; Khan SR
J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
[TBL] [Abstract][Full Text] [Related]
27. Renal peroxidative changes mediated by oxalate: the protective role of fucoidan.
Veena CK; Josephine A; Preetha SP; Varalakshmi P; Sundarapandiyan R
Life Sci; 2006 Oct; 79(19):1789-95. PubMed ID: 16820173
[TBL] [Abstract][Full Text] [Related]
28. Chenopodium album Linn. leaves prevent ethylene glycol-induced urolithiasis in rats.
Sikarwar I; Dey YN; Wanjari MM; Sharma A; Gaidhani SN; Jadhav AD
J Ethnopharmacol; 2017 Jan; 195():275-282. PubMed ID: 27864113
[TBL] [Abstract][Full Text] [Related]
29. Antiurolithic effect of lupeol and lupeol linoleate in experimental hyperoxaluria.
Sudhahar V; Veena CK; Varalakshmi P
J Nat Prod; 2008 Sep; 71(9):1509-12. PubMed ID: 18717586
[TBL] [Abstract][Full Text] [Related]
30. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
Li Y; McMartin KE
Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
[TBL] [Abstract][Full Text] [Related]
31. High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys.
Huang HS; Ma MC
PLoS One; 2015; 10(8):e0134764. PubMed ID: 26241473
[TBL] [Abstract][Full Text] [Related]
32. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
33. Protective impact of resveratrol in experimental rat model of hyperoxaluria.
Oksay T; Yunusoğlu S; Calapoğlu M; Aydın Candan I; Onaran İ; Ergün O; Özorak A
Int Urol Nephrol; 2017 May; 49(5):769-775. PubMed ID: 28185107
[TBL] [Abstract][Full Text] [Related]
34. The effect of L-arginine methyl ester on indices of free radical involvement in a rat model of experimental nephrocalcinosis.
Ozturk H; Ozturk H; Yagmur Y; Buyukbayram H
Urol Res; 2006 Oct; 34(5):305-14. PubMed ID: 16823549
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial dysfunction in an animal model of hyperoxaluria: a prophylactic approach with fucoidan.
Veena CK; Josephine A; Preetha SP; Rajesh NG; Varalakshmi P
Eur J Pharmacol; 2008 Jan; 579(1-3):330-6. PubMed ID: 18001705
[TBL] [Abstract][Full Text] [Related]
36. Nephrocalcinosis induced by hyperoxaluria in rats.
Cunha NB; Kawano PR; Padovani CR; Lima Fde O; Bernardes S; Magalhães ES; Amaro CR; Amaro JL
Acta Cir Bras; 2013 Jul; 28(7):496-501. PubMed ID: 23842930
[TBL] [Abstract][Full Text] [Related]
37. Herbo-Mineral Medicine, Lithom Exhibits Anti-Nephrolithiasis Activity in Rat Model of Hyperoxaluria by Attenuating Calcium Oxalate Crystal Formation and Oxidative Stress.
Balkrishna A; Sinha S; Manik M; Pandey A; Maity M; Dev R; Varshney A
Discov Med; 2024 Apr; 36(183):799-815. PubMed ID: 38665028
[TBL] [Abstract][Full Text] [Related]
38. The preventive effects of Ulva lactuca aqueous extract, ulvan polysaccharides and atorvastatin on ethylene glycol-induced hyperoxaluria.
Abdelaziz MA; Ahmed OM; Abdel-Gabbar M; Mohammad MR; Ibrahim SR; Abdelzaher MH; Mohideen AP; Moawd SA; Geddawy AI
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3699-3713. PubMed ID: 37140319
[TBL] [Abstract][Full Text] [Related]
39. Effect of gamma-glutamyl carboxylation of renal microsomes on calcium oxalate monohydrate crystal binding in hyperoxaluria.
Angayarkanni N; Selvam R
Nephron; 1999; 81(3):342-6. PubMed ID: 10050091
[TBL] [Abstract][Full Text] [Related]
40. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
Khan SR; Glenton PA; Byer KJ
Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
